Uropathology January Jon Oxley

Similar documents
PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA AND IMPORTANT MIMICKERS PROSTATIC ADENOCARCINOMA: DIAGNOSTIC CRITERIA

Prostate Immunohistochemistry. Literature Interpretation: Caveats. Must be aware of staining pattern of antibody in the relevant tissue

PSA. HMCK, p63, Racemase. HMCK, p63, Racemase

They Do Look Alike : Mimics of Prostate Cancer in Biopsy Samples

Prostate Pathology: Prostate Carcinoma, variants and Gleason Grading (Part 1)

FINALIZED SEER SINQ QUESTIONS

Kidney, Bladder and Prostate Neoplasia. David Bingham MD

INTRADUCTAL LESIONS OF THE PROSTATE. Jonathan I. Epstein

5/21/2018. Difficulty in Underdiagnosing Prostate Cancer. Diagnosis of Prostate Cancer. Evaluation of Prostate Cancer and Atypical on Needle Biopsy

3/28/2017. Disclosure of Relevant Financial Relationships. GU Evening Subspecialty Case Conference. Differential Diagnosis:

Macro- and microacinar proliferations of the prostate

Gross appearance of nodular hyperplasia in material obtained from suprapubic prostatectomy. Note the multinodular appearance and the admixture of

ARTHUR PURDY STOUT SOCIETY COMPANION MEETING: DIFFICULT NEW DIFFERENTIAL DIAGNOSES IN PROSTATE PATHOLOGY. Jonathan I. Epstein.

Penile cancer teams in UK. Common variants. Penile cancer teams. Basaloid squamous carcinoma. The Pathology of Penile Tumours

Prostate Biopsy Interpretation: An Illustrated Guide

Outline (1) Outline (2) Concepts in Prostate Pathology. Peculiarities of Prostate Cancer. Peculiarities of Prostate Cancer

ACCME/Disclosures. Cribriform Lesions of the Prostate. Case

Synonyms. Nephrogenic metaplasia Mesonephric adenoma

2016 WHO CLASSIFICATION OF TUMOURS OF THE PROSTATE. Peter A. Humphrey, MD, PhD Yale University School of Medicine New Haven, CT

Diagnosis, pathology and prognosis including variant pathology

Urinary Bladder: WHO Classification and AJCC Staging Update 2017

Gleason Scoring System 2017 JASREMAN DHILLON, MD ASSOCIATE PROFESSOR, DEPARTMENT OF ANATOMIC PATHOLOGY, MOFFITT CANCER CENTER, TAMPA, FLORIDA

Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance

ISPUB.COM. Interpretation Of Prostatic Biopsies: A Review. A Chitale, S Khubchandani INTRODUCTION NON-NEOPLASTIC LESIONS GRADING: GLEASON'S SCORE

Pathology of the Prostate. PathoBasic Tatjana Vlajnic

Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial Carcinoma

Breast pathology. 2nd Department of Pathology Semmelweis University

Prostate cancer staging and datasets: The Nitty-Gritty. What determines our pathological reports? 06/07/2018. Dan Berney Maastricht 2018

CODING TUMOUR MORPHOLOGY. Otto Visser

Although current American Cancer Society guidelines

Prostate cancer ~ diagnosis and impact of pathology on prognosis ESMO 2017

2 to 3% of All New Visceral Cancers Peak Incidence is 6th Decade M:F = 2:1 Grossly is a Bright Yellow, Necrotic Mass with a Pseudocapsule

LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR

ACCME/Disclosures. 52 year old man who consulted for a long-standing mass on the distal penis 4/13/2016

5/21/2018. Prostate Adenocarcinoma vs. Urothelial Carcinoma. Common Differential Diagnoses in Urological Pathology. Jonathan I.

Atypical Hyperplasia/EIN

Case #1: 75 y/o Male (treated and followed by prostate cancer oncology specialist ).

Immunohistochemistry and Bladder Tumours

Grading Prostate Cancer: Recent Changes and Refinements

Updates in Urologic Pathology WHO Made Those Changes?! Peyman Tavassoli Pathology Department BC Cancer Agency

Tumour Structure and Nomenclature. Paul Edwards. Department of Pathology and Cancer Research UK Cambridge Institute, University of Cambridge

Mody. AIS vs. Invasive Adenocarcinoma of the Cervix

Prostatic ductal adenocarcinoma is a subtype of

4/17/2015. Case 1. A 37 year old man with a 2.2 cm solitary left thyroid mass.

Slide seminar. Asist. Prof. Jože Pižem, MD, PhD Institute of Pathology Medical Faculty, University of Ljubljana

05/07/2018. Types of challenges. Challenging cases in uterine pathology. Case 1 ` 65 year old female Post menopausal bleeding Uterine Polyp

Immunohistochemistry in prostate pathology: Recent Advances

DATA STANDARDS AND QUALITY CONTROL MEMORANDUM DSQC #

Papillary Lesions of the breast

Internationally indexed journal

Dissertation submitted in. Partial fulfilment of the regulations required for the award of M.D. DEGREE PATHOLOGY BRANCH III THE TAMILNADU

CLINICAL SIGNIFICANCE OF BENIGN EPITHELIAL CHANGES

Giant Multilocular Cystadenoma of the Prostate A Potential Pitfall On Needle Core Biopsy

Department of Diagnostic Pathology, Kochi Red Cross Hospital, Kochi, Japan

Epithelial Columnar Breast Lesions: Histopathology and Molecular Markers

International London Uropathology Conference 2014

A re-audit of Prostate biopsies from January to December 2010 and 2013.

Mesothelioma: diagnostic challenges from a pathological perspective. Naseema Vorajee August 2016

3/23/2017. Significant Changes in Prostate Cancer Classification, Grading, Staging and Reporting. Disclosure of Relevant Financial Relationships

Review of the AP Part II Practical Examination. Dr David Clift Co Chief Examiner

Case 18. M75. Excision of mass on scalp. Clinically SCC. The best diagnosis is:

Update on Bladder Cancer: What s New in the 2016 WHO Classification of Bladder Tumors and 8 th Edition of AJCC Staging Manual

Cutaneous Adnexal Tumors

Oncocytic-Appearing Salivary Gland Tumors. Oncocytic, Cystic, Mucinous, and High Grade Salivary Gland Tumors SALIVARY GLAND FNA: PART II

Educational Cases EQA November T.J. Palmer Raigmore Hospital Inverness

Dr Sanjiv Manek Oxford. Oxford Pathology Course 2010 for FRCPath Illustration-Cellular Pathology. Oxford Radcliffe NHS Trust

Appendix 4: WHO Classification of Tumours of the pancreas 17

B asal cell proliferations in the prostate gland exhibit a

Mousa. Israa Ayed. Abdullah AlZibdeh. 0 P a g e

Demystifying Endometrial Hyperplasia

Classification (1) Classification (3) Classification (2) Spindle cell lesions. Spindle cell lesions of bladder (Mills et al.

Study of High Grade Prostatic Intraepithelial Neoplasia for a Period of Five Years B. Rajashekar Reddy 1, Rameswarapu Suman Babu 2 and P.

Spindle Cell Lesions Of The Breast. Emad Rakha Professor of Breast Pathology and Consultant Pathologist

6/3/2010. Outline of Talk. Lobular Breast Cancer: Definition of lobular differentiation. Common Problems in Diagnosing LCIS in Core Biopsies

Breast Pathology. Breast Development

Rare Tumours of Male Genital Organs

Procedures Needle Biopsy Transurethral Prostatic Resection Suprapubic or Retropubic Enucleation (Subtotal Prostatectomy) Radical Prostatectomy

Treatment options for the precancerous Atypical Breast lesions. Prof. YOUNG-JIN SUH The Catholic University of Korea

What is New in the 2015 WHO Lung Cancer Classification? Zhaolin Xu, MD, FRCPC, FCAP

CHRONIC PANCREATITIS OR DUCTAL ADENOCARCINOMA? N. Volkan Adsay, \ MD

Basal cell carcinoma 5/28/2011

04/10/2018. Intraductal Papillary Neoplasms Of Breast INTRADUCTAL PAPILLOMA

Prostate Cancer Grading, Staging and Reporting: An Update Cristina Magi-Galluzzi, MD, PhD

Normal endometrium: A, proliferative. B, secretory.

Prostatic stromal hyperplasia with atypia (PSHA) is a

1 NORMAL HISTOLOGY AND METAPLASIAS

Lung Tumor Cases: Common Problems and Helpful Hints

Neoplasia 2018 Lecture 2. Dr Heyam Awad MD, FRCPath

Histological Typing Of Cancer And Precancer Of The Oral Mucosa

Benign Breast Disease and Breast Cancer Risk

List of Available TMAs in the PRN

The Pathologist s Role in the Diagnosis and Management of Neoplasia in Barrett s Oesophagus Cian Muldoon, St. James s Hospital, Dublin

Salivary Gland Cytology

Chapter 3. Neoplasms. Copyright 2015 Cengage Learning.

FINALIZED SEER SINQ QUESTIONS April July, 2017

Urological Tumours 1 Kidney tumours 2 Bladder tumours

!! 2 to 3% of All New Visceral Cancers.!! Peak Incidence is 6th Decade!! M:F = 2:1

4/12/2018. MUSC Pathology Symposium Kiawah Island April 18, Jesse K. McKenney, MD

EAU GUIDELINES ON PENILE CANCER

Precursor lesions to most urologic malignancies are

Transcription:

Uropathology January 2012 Jon Oxley

Background to seminar These slides were available to view via the web from scanned slides The junior pathologists answered questions on them via the web The answers given, Gleason scores etc are also in this presentation, highlighting the problems of subjectivity of Gleason scoring.

Case 1 Prostate 39 Clinical History: 33M lump in prostate Macro: TURP Immunohistochemistry: CD34 positive stroma

Diagnoses offered STUMP (6) Solitary fibrous tumour (3) Benign Stromal lesion (2) Atypical lipoma (1) Stromal sarcoma (2) Sclerosing adenosis (1)

Diagnosis: Stromal proliferation of uncertain malignant potential (STUMP) Hypercellular stroma +/- cytologic atypia, +/- glandular component Phylloides like pattern CD34 and progesterone receptor +ve Desmin, SMA +ve (-ve in PSS) c/w prostatic stromal sarcoma (PSS)higher cellularity, nuclear atypia, necrosis

45yr lesion on glans Case 2 - Penis 9

Diagnoses offered SCC (3) SCC in situ (1) Dysplasia falling short of CIS (1) Condyloma (4) giant condyloma (1) BXO (1) Zoon s (1)

Diagnosis: Penile squamous cell carcinoma with background differentiated PeIN SCC rare, approx 70 cases per year in SW super network. Severe dysplasia, carcinoma in situ, PeIN3, Bowen s disease, erythroplasia of Queyrat all interchangable and best to stick to carcinoma in situ Differential diagnosis of Bowenoid papulosis in young but clinically different (multiple papules in Bowenoid papulosis) Recognise Differentiated PeIN just the basal layer is atypical P16 expressed by basaloid subtypes of CIS.

References Oertell J,et al. Differentiated precursor lesions and low-grade variants of squamous cell carcinomas are frequent findings in foreskins of patients from a region of high penile cancer incidence. Histopathology. 2011 May;58(6):925-33. Chaux A, et al. Distinctive immunohistochemical profile of penile intraepithelial lesions: a study of 74 cases. Am J Surg Pathol. 2011 Apr;35(4):553-62.

Case 3 Prostate 47 63M TURP There are two pathologies present select both, and Gleason score

Diagnoses offered CaP Microacinar (8) CaP Ductal (1) CaP Colloid (1) PIN (1) Acute inflammation (2) Atrophy (1) TCC (2)

Diagnosis: Prostate cancer with TCC in ducts At cystectomies for TCC approx 70% of prostates contain CaP. Always assess and comment on urothelium of TURPs. Assessing invasion of TCC outside ducts always difficult foci of inflammation are often a hint that invasion has occurred. TCC = 34BE12, p63 and CK7 positive

Gleason score Not relevant 3+3 3+4 4+3 4+4 4+5 5+5 Primary diagnosis 0.0% (0) 20.0% (2) 50.0% (5) 0.0% (0) 10.0% (1) 10.0% (1) 10.0% (1) 10 Second diagnosis 70.0% (7) 20.0% (2) 0.0% (0) 10.0% (1) 0.0% (0) 0.0% (0) 0.0% (0) 10

Case 4 Prostate 5 77M, prostatic chips There are two pathologies present select both, and Gleason score.

Diagnoses offered Lymphoma (7) Leukaemia (1) Acute prostatitis (2) CaP microacinar (6) CaP Ductal (2) Metastatic tumour (1) Germ cell tumour (1)

Diagnosis: CaP + CLL TURP s are often performed in elderley patients who often have unsuspected CLL. Simple immunopanel CD3,CD5, CD20, CD23 Check blood counts Refer to haematology Hint lymphocytes associated with blood vessels and not acini.

Gleason score Not relevant 3+3 3+4 4+3 4+4 4+5 5+5 Primary diagnosis 30.0% (3) 10.0% (1) 10.0% (1) 30.0% (3) 0.0% (0) 20.0% (2) 0.0% (0) 10 Second diagnosis 90.0% (9) 0.0% (0) 10.0% (1) 0.0% (0) 0.0% (0) 0.0% (0) 0.0% (0) 10

Case 5 Prostate 22 72M PSA 13 DRE Benign Answer all parts to question Gleason score Volume

Diagnoses offered CaP Ductal (1) CaP Foamy (3) CaP Microacinar (3) CaP pseudohyperplastic (1) PIN (1)

Diagnosis: Foamy gland CaP Trap as bland at low power 34BE12 very useful AMACR no use as can be negative Hint nucleoli in this case but can sometime lack this low threshold for 34BE12

Gleason score 3+3 3+4 4+3 4+4 4+5 5+5 50.0% (5) 40.0% (4) 0.0% (0) 10.0% (1) 0.0% (0) 0.0% (0) 10

Volume <5% 5-10% 11-20% 21-30% 31-40% 41-50% 51-60% 61-70% >70% 20.0% (2) 20.0% (2) 10.0% (1) 10.0% (1) 20.0% (2) 0.0% (0) 0.0% (0) 10.0% (1) 10.0% (1) 10

72yr old TURP. Case 6 Prostate 43

Diagnoses offered CaP endocrine differentiation (5) CaP Microacinar (2) Basal cell carcinoma (2) Basal cell hyperplasia (1) TCC (3) Small cell (1) Carcinoid (1)

Diagnosis: Carcinoid Very rare primary carcinoid (most commonly metastatic) Typical immunophenotype = CG, CD56,synaptophysin Differential = Small cell carcinoma commonly post CaP post hormone therapy beware bladder small cell invading prostate. Primary small cell carcinoma of prostate does occur but very rare.

Case 7 Prostate 9 75M PSA 5.8, core There are two pathologies present select both, and Gleason score

Diagnoses offered CaP microacinar (8) CaP ductal (1) PIN (2) Amyloid (2) Atrophy (3) Sclerosing adenosis (1) Seminal vesicle

Diagnosis: CaP with seminal vesicle amyloid Amyloid seen in seminal vesicle in about 1% of radical prostates. Derived from semenogelin I (involved in the formation of a gel matrix that encases ejaculated spermatozoa, and is degraded by the proteolytic action of prostate specific antigen/psa ) No clinical significance

Gleason Score Not relevant 3+3 3+4 4+3 4+4 4+5 5+5 11.1% (1) 11.1% (1) 0.0% (0) 44.4% (4) 0.0% (0) 33.3% (3) 0.0% (0) 9

Case 8 Prostate 29A 64M?TCC in prostatic fossa

Diagnoses offered CaP Ductal (5) CaP Pseudohyperplastic (1) Adenocarcinoma not prostatic (2) Nephrogenic adenoma (1) PIN (3) TCC (2)

Diagnosis: Ductal carcinoma of the Gleason pattern 4 prostate PSA +ve, 34BE12 ve (can grow into ducts so basal layer can be highlighted) Often co-exist with microacinar. Don t mistake it for TCC!!

Gleason Score Not relevant 3+3 3+4 4+3 4+4 4+5 5+5 66.7% (6) 0.0% (0) 0.0% (0) 0.0% (0) 33.3% (3) 0.0% (0) 0.0% (0) 9

Case 9 Prostate 14 65M PSA 7.4 There are two pathologies present select both, and Gleason score

Diagnoses offered CaP microacinar (5) CaP Colloid (1), endocrine (1), foamy (1) PIN (1) TCC (1) Angiosarcoma (1) Seminal vesicle (1), cribriform clear cell (1) Adenosis (3), BPH (1), mesonephric remnant (1)

Diagnosis: Inverted growth pattern HGPIN and CaP Rare subtype (I have never seen it without cancer) Usual type of HGPIN seen in 5% of cores (varies considerably)

Gleason Score Not relevant 3+3 3+4 4+3 4+4 4+5 5+5 55.6% (5) 33.3% (3) 0.0% (0) 0.0% (0) 0.0% (0) 11.1% (1) 0.0% (0) 9 55.6% (5) 33.3% (3) 0.0% (0) 0.0% (0) 11.1% (1) 0.0% (0) 0.0% (0) 9

Case 10 - Penis 65yr lesion on glans and foreskin.

Diagnoses offered Melanoma (8) Basaloid carcinoma (2) Merkel carcinoma (3) SCC (1)

Diagnosis : Penile melanoma Poor prognosis often delay presentation BRAF and KIT mutations described but not detected in our series.

Opinion on trial Using the images was easy The speed was acceptable Quality of image was excellent More tutorials should use this I recommend the process for future tutorials Strongly disagree Disagree Neutral Agree Strongly agree 0.0% (0) 0.0% (0) 50.0% (5) 50.0% (5) 0.0% (0) 0.0% (0) 20.0% (2) 10.0% (1) 70.0% (7) 0.0% (0) 0.0% (0) 20.0% (2) 30.0% (3) 40.0% (4) 10.0% (1) 0.0% (0) 20.0% (2) 50.0% (5) 20.0% (2) 10.0% (1) 0.0% (0) 30.0% (3) 30.0% (3) 30.0% (3) 10.0% (1) This is the future 20.0% (2) 20.0% (2) 0.0% (0) 50.0% (5) 10.0% (1) 1 0 1 0 1 0 1 0 1 0 1 0 total number of responses = 10

REFERENCES Genitourinary Pathology: A Volume in Foundations in Diagnostic Pathology Series, by Zhou.